プロテオミクス市場：技術、機器タイプ、サービス、用途、エンドユーザー別-2025-2030年の世界予測

プロテオミクス市場は、2023年に317億8,000万米ドルと評価され、2024年には360億5,000万米ドルに達すると予測され、CAGR 14.67％で成長し、2030年には829億米ドルになると予測されています。

プロテオミクスは、タンパク質、その構造、機能に関する広範な研究分野であり、生物学的プロセスやメカニズムを理解する上で極めて重要です。その中核となるプロテオミクスの調査範囲は、タンパク質の同定から相互作用の解析にまで及び、個別化医療や創薬の進歩に貢献しています。プロテオミクスの必要性は、複雑な細胞機能を解明し、疾病メカニズムや治療介入の有効性をより深く洞察する可能性にあります。その用途は臨床診断、バイオマーカー探索、システム生物学に及び、最終用途は製薬、バイオテクノロジー、学術研究などです。市場の洞察によると、主要な成長要因としては、質量分析技術の進歩、創薬における研究活動の増加、個別化医療に対する需要の高まりなどが挙げられます。次世代のプロテオミクステクノロジーの開発、未開拓の新興国市場への進出、研究開発能力を強化するための戦略的パートナーシップの構築など、潜在的なビジネスチャンスは豊富にあります。このような機会を捉えるために、企業は費用対効果の高いハイスループット技術の開発に注力すると同時に、プロテオミクス分野での資金提供や協力体制の強化を提唱すべきです。しかしながら、この市場は、装置の高コストや技術の複雑さといった限界にも直面しており、より広範な普及を阻む大きな障壁となっています。標準化の断片化、熟練者の不足、データ管理の課題などが、成長の見通しをさらに複雑にしています。このような課題にもかかわらず、技術革新が期待される分野には、プロテオミクスとゲノミクスや他のオミックス領域との統合、AI主導のデータ解析ツールの開発、再現性を向上させるための手法標準化の強化などがあります。プロテオミクス市場は本質的にダイナミックで競争が激しく、急速な技術革新と絶え間ない進化を特徴としているため、プレーヤーは課題に対処し新たな需要に応えるために機敏な戦略を維持することが不可欠です。競争力を維持するために、企業は研究開発への継続的な投資を行い、学際的なコラボレーションを促進し、進化する市場ニーズに沿った顧客中心のアプローチを優先すべきです。

市場力学：急速に進化するプロテオミクス市場の主要市場インサイトを公開

プロテオミクス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • がん治療における利用の増加と個別化医療の必要性
  • プロテオミクス研究のためのバイオインフォマティクス・ソフトウェア＆サービスの採用増加
  • ヒトプロテオーム組織とプロテオミクス標準に対する政府の取り組み
• 市場抑制要因
  • プロテオミクスデータリポジトリ管理に伴う高コスト
• 市場機会
  • プロテオミクス技術の研究開発への多額の投資
  • プロテオミクスバイオマーカー探索への新たな投資
• 市場の課題
  • プロテオミクスにおけるペプチド同定の限界

ポーターの5つの力：プロテオミクス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、プロテオミクス市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：プロテオミクス市場における外部からの影響の把握

外部マクロ環境要因は、プロテオミクス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析プロテオミクス市場における競合情勢の把握

プロテオミクス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスプロテオミクス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、プロテオミクス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨プロテオミクス市場における成功への道筋を描く

プロテオミクス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • がん治療における使用の増加と個別化医療の必要性
    • プロテオミクス研究におけるバイオインフォマティクスソフトウェアとサービスの採用増加
    • ヒトプロテオーム組織化とプロテオミクス標準に関する政府の取り組み
  • 抑制要因
    • プロテオミクスデータリポジトリ管理に関連する高コスト
  • 機会
    • プロテオミクス技術の調査開発への多額の投資
    • プロテオミクスバイオマーカー発見への新たな投資
  • 課題
    • プロテオミクスにおけるペプチド識別の制限
• 市場セグメンテーション分析
  • テクノロジー：精度と信頼性によるクロマトグラフィーの需要の高まり
  • 応用：病気の早期発見、予後、個別化治療戦略のための臨床診断におけるプロテオミクスの活用
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 プロテオミクス市場：技術別

• クロマトグラフィー
  • アフィニティークロマトグラフィー
  • ガスクロマトグラフィー
  • イオンクロマトグラフィー
  • 液体クロマトグラフィー
  • 表面クロマトグラフィー
• エドマンシーケンス
• 電気泳動
  • キャピラリー電気泳動
  • ゲル電気泳動
• 質量分析
  • フーリエ変換質量分析法
  • タンデム質量分析法
• タンパク質分画
• タンパク質マイクロアレイ
  • バイオチップ
  • 機能性タンパク質マイクロアレイ
• 表面プラズモン共鳴
• X線結晶構造解析

第7章 プロテオミクス市場楽器の種類別

• 分析機器
  • クロマトグラフィー機器
  • 分光計
• 試薬・消耗品
  • バッファ
  • 染料
• ソフトウェア
  • バイオインフォマティクスデータベース
  • バイオインフォマティクスツール
  • データ収集ソフトウェア
  • データ分析ソフトウェア

第8章 プロテオミクス市場：サービス別

• バイオインフォマティクスサービス
• コアプロテオミクスサービス

第9章 プロテオミクス市場：用途別

• バイオマーカーの特定
  • がんバイオマーカー
  • 心血管バイオマーカー
• 臨床診断
  • 病気の診断
  • 治療薬モニタリング
• 創薬
  • リード化合物の特定
  • ターゲット識別

第10章 プロテオミクス市場：エンドユーザー別

• 学術調査機関
  • 中核調査施設
  • 大学の研究室
• 病院および診断センター
  • 臨床検査部門
  • 病理学研究室
• 製薬会社
  • 医薬品製造ユニット
  • 研究開発研究所

第11章 南北アメリカのプロテオミクス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域のプロテオミクス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカのプロテオミクス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • SPOCプロテオミクスはベータテスト用にカスタマイズ可能なSPOCバイオセンサーを発売し、プロテオミクスを変革する画期的なSPRテクノロジーを発表しました。
  • ブルカーは、高度なソフトウェア統合により単一細胞プロテオミクスを強化した最先端の質量分析装置timsTOF Ultra 2を発売しました。
  • BiognosysとAlamar Biosciencesが提携し、NULISAアッセイを統合し、高度なプロテオミクス調査のためのDIA-MSプラットフォームを強化
• 戦略分析と提言

企業一覧

• Agilent Technologies, Inc.
• Applied Biomics, Inc.
• Bio-Rad Laboratories, Inc.
• Biognosys AG
• Bruker Corporation
• Cellenion SASU by Bico Group AB
• Charles River Laboratories, Inc.
• Creative Biolabs, Inc.
• Creative Proteomics
• Danaher Corporation
• GE Healthcare
• Illumina, Inc.
• IsoPlexis Corporation
• Luminex Corporation
• Merck KGaA
• MRM Proteomics, Inc.
• Nautilus Biotechnology Inc.
• NEO Proteomics, Inc.
• Olink Holding AB
• Perkinelmer, Inc.
• Poochon Scientific, LLC
• Precision Proteomics Inc.
• Promega Corporation
• PROMISE Proteomics
• Proteome Sciences PLC
• Proteomics International
• Shantani Proteome Analytics Pvt. Ltd.
• Thermo Fisher Scientific, Inc.
• VProteomics
• Waters Corporation

LIST OF FIGURES

• FIGURE 1. PROTEOMICS MARKET RESEARCH PROCESS
• FIGURE 2. PROTEOMICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PROTEOMICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PROTEOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PROTEOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PROTEOMICS MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PROTEOMICS MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL PROTEOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL PROTEOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL PROTEOMICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL PROTEOMICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS PROTEOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS PROTEOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES PROTEOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES PROTEOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. PROTEOMICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. PROTEOMICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PROTEOMICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PROTEOMICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PROTEOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PROTEOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PROTEOMICS MARKET DYNAMICS
• TABLE 7. GLOBAL PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PROTEOMICS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PROTEOMICS MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PROTEOMICS MARKET SIZE, BY ION CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PROTEOMICS MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PROTEOMICS MARKET SIZE, BY SUPERFICIAL CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PROTEOMICS MARKET SIZE, BY EDMAN SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PROTEOMICS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PROTEOMICS MARKET SIZE, BY GEL ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PROTEOMICS MARKET SIZE, BY FOURIER TRANSFORM MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PROTEOMICS MARKET SIZE, BY TANDEM MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL PROTEOMICS MARKET SIZE, BY PROTEIN FRACTIONATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL PROTEOMICS MARKET SIZE, BY BIOCHIP, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL PROTEOMICS MARKET SIZE, BY FUNCTIONAL PROTEIN MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL PROTEOMICS MARKET SIZE, BY SURFACE PLASMON RESONANCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL PROTEOMICS MARKET SIZE, BY X RAY CRYSTALLOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL PROTEOMICS MARKET SIZE, BY SPECTROMETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL PROTEOMICS MARKET SIZE, BY BUFFERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL PROTEOMICS MARKET SIZE, BY STAINS & DYES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL PROTEOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL PROTEOMICS MARKET SIZE, BY BIOINFORMATICS DATABASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL PROTEOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL PROTEOMICS MARKET SIZE, BY DATA ACQUISITION SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL PROTEOMICS MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 46. GLOBAL PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 47. GLOBAL PROTEOMICS MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 48. GLOBAL PROTEOMICS MARKET SIZE, BY CORE PROTEOMICS SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 49. GLOBAL PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. GLOBAL PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 51. GLOBAL PROTEOMICS MARKET SIZE, BY CANCER BIOMARKERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 52. GLOBAL PROTEOMICS MARKET SIZE, BY CARDIOVASCULAR BIOMARKERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 53. GLOBAL PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
• TABLE 54. GLOBAL PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 55. GLOBAL PROTEOMICS MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 56. GLOBAL PROTEOMICS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 57. GLOBAL PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 58. GLOBAL PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 59. GLOBAL PROTEOMICS MARKET SIZE, BY LEAD COMPOUND IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 60. GLOBAL PROTEOMICS MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 61. GLOBAL PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 62. GLOBAL PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. GLOBAL PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 64. GLOBAL PROTEOMICS MARKET SIZE, BY CORE RESEARCH FACILITIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 65. GLOBAL PROTEOMICS MARKET SIZE, BY UNIVERSITY LABS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 66. GLOBAL PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 67. GLOBAL PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 68. GLOBAL PROTEOMICS MARKET SIZE, BY CLINICAL TESTING DEPARTMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 69. GLOBAL PROTEOMICS MARKET SIZE, BY PATHOLOGY LABS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 70. GLOBAL PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
• TABLE 71. GLOBAL PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 72. GLOBAL PROTEOMICS MARKET SIZE, BY DRUG MANUFACTURING UNIT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 73. GLOBAL PROTEOMICS MARKET SIZE, BY R&D LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 74. GLOBAL PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
• TABLE 75. AMERICAS PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 76. AMERICAS PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 77. AMERICAS PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 78. AMERICAS PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 79. AMERICAS PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
• TABLE 80. AMERICAS PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 81. AMERICAS PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 82. AMERICAS PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 83. AMERICAS PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 84. AMERICAS PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 85. AMERICAS PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. AMERICAS PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
• TABLE 87. AMERICAS PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 88. AMERICAS PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 89. AMERICAS PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. AMERICAS PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 91. AMERICAS PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
• TABLE 92. AMERICAS PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
• TABLE 93. AMERICAS PROTEOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 94. ARGENTINA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 95. ARGENTINA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 96. ARGENTINA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 97. ARGENTINA PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 98. ARGENTINA PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
• TABLE 99. ARGENTINA PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 100. ARGENTINA PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 101. ARGENTINA PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 102. ARGENTINA PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 103. ARGENTINA PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 104. ARGENTINA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. ARGENTINA PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
• TABLE 106. ARGENTINA PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 107. ARGENTINA PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 108. ARGENTINA PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 109. ARGENTINA PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 110. ARGENTINA PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
• TABLE 111. ARGENTINA PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
• TABLE 112. BRAZIL PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 113. BRAZIL PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 114. BRAZIL PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 115. BRAZIL PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 116. BRAZIL PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
• TABLE 117. BRAZIL PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 118. BRAZIL PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 119. BRAZIL PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 120. BRAZIL PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 121. BRAZIL PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 122. BRAZIL PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. BRAZIL PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
• TABLE 124. BRAZIL PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 125. BRAZIL PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 126. BRAZIL PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 127. BRAZIL PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 128. BRAZIL PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
• TABLE 129. BRAZIL PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
• TABLE 130. CANADA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 131. CANADA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 132. CANADA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 133. CANADA PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 134. CANADA PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
• TABLE 135. CANADA PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 136. CANADA PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 137. CANADA PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 138. CANADA PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 139. CANADA PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 140. CANADA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. CANADA PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
• TABLE 142. CANADA PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 143. CANADA PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 144. CANADA PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 145. CANADA PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 146. CANADA PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
• TABLE 147. CANADA PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
• TABLE 148. MEXICO PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 149. MEXICO PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 150. MEXICO PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 151. MEXICO PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 152. MEXICO PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
• TABLE 153. MEXICO PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 154. MEXICO PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 155. MEXICO PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 156. MEXICO PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 157. MEXICO PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 158. MEXICO PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. MEXICO PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
• TABLE 160. MEXICO PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 161. MEXICO PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 162. MEXICO PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 163. MEXICO PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 164. MEXICO PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
• TABLE 165. MEXICO PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
• TABLE 166. UNITED STATES PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 167. UNITED STATES PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 168. UNITED STATES PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 169. UNITED STATES PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 170. UNITED STATES PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
• TABLE 171. UNITED STATES PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 172. UNITED STATES PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 173. UNITED STATES PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 174. UNITED STATES PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 175. UNITED STATES PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 176. UNITED STATES PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. UNITED STATES PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
• TABLE 178. UNITED STATES PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 179. UNITED STATES PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 180. UNITED STATES PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 181. UNITED STATES PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 182. UNITED STATES PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
• TABLE 183. UNITED STATES PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
• TABLE 184. UNITED STATES PROTEOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 185. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 186. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 187. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 188. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 189. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
• TABLE 190. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 191. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 192. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 193. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 194. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 195. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 196. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
• TABLE 197. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 198. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 199. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 200. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 201. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
• TABLE 202. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
• TABLE 203. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 204. AUSTRALIA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 205. AUSTRALIA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 206. AUSTRALIA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 207. AUSTRALIA PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 208. AUSTRALIA PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
• TABLE 209. AUSTRALIA PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 210. AUSTRALIA PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 211. AUSTRALIA PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 212. AUSTRALIA PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 213. AUSTRALIA PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 214. AUSTRALIA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 215. AUSTRALIA PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
• TABLE 216. AUSTRALIA PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 217. AUSTRALIA PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 218. AUSTRALIA PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 219. AUSTRALIA PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 220. AUSTRALIA PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
• TABLE 221. AUSTRALIA PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
• TABLE 222. CHINA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 223. CHINA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 224. CHINA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 225. CHINA PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 226. CHINA PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
• TABLE 227. CHINA PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 228. CHINA PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 229. CHINA PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 230. CHINA PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 231. CHINA PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 232. CHINA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 233. CHINA PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
• TABLE 234. CHINA PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 235. CHINA PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 236. CHINA PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 237. CHINA PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 238. CHINA PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
• TABLE 239. CHINA PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
• TABLE 240. INDIA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 241. INDIA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 242. INDIA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 243. INDIA PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 244. INDIA PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
• TABLE 245. INDIA PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 246. INDIA PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 247. INDIA PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 248. INDIA PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 249. INDIA PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 250. INDIA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 251. INDIA PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
• TABLE 252. INDIA PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 253. INDIA PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 254. INDIA PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 255. INDIA PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 256. INDIA PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
• TABLE 257. INDIA PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
• TABLE 258. INDONESIA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 259. INDONESIA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 260. INDONESIA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 261. INDONESIA PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 262. INDONESIA PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
• TABLE 263. INDONESIA PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 264. INDONESIA PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 265. INDONESIA PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 266. INDONESIA PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 267. INDONESIA PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 268. INDONESIA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 269. INDONESIA PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
• TABLE 270. INDONESIA PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 271. INDONESIA PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 272. INDONESIA PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 273. INDONESIA PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 274. INDONESIA PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
• TABLE 275. INDONESIA PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
• TABLE 276. JAPAN PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 277. JAPAN PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 278. JAPAN PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 279. JAPAN PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 280. JAPAN PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
• TABLE 281. JAPAN PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 282. JAPAN PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 283. JAPAN PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 284. JAPAN PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 285. JAPAN PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 286. JAPAN PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 287. JAPAN PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
• TABLE 288. JAPAN PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 289. JAPAN PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 290. JAPAN PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 291. JAPAN PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 292. JAPAN PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
• TABLE 293. JAPAN PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
• TABLE 294. MALAYSIA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 295. MALAYSIA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 296. MALAYSIA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 297. MALAYSIA PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 298. MALAYSIA PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
• TABLE 299. MALAYSIA PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 300. MALAYSIA PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 301. MALAYSIA PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 302. MALAYSIA PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 303. MALAYSIA PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 304. MALAYSIA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 305. MALAYSIA PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
• TABLE 306. MALAYSIA PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 307. MALAYSIA PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 308. MALAYSIA PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 309. MALAYSIA PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 310. MALAYSIA PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
• TABLE 311. MALAYSIA PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
• TABLE 312. PHILIPPINES PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 313. PHILIPPINES PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 314. PHILIPPINES PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 315. PHILIPPINES PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 316. PHILIPPINES PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
• TABLE 317. PHILIPPINES PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 318. PHILIPPINES PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 319. PHILIPPINES PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 320. PHILIPPINES PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 321. PHILIPPINES PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 322. PHILIPPINES PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 323. PHILIPPINES PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
• TABLE 324. PHILIPPINES PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 325. PHILIPPINES PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 326. PHILIPPINES PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 327. PHILIPPINES PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 328. PHILIPPINES PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
• TABLE 329. PHILIPPINES PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
• TABLE 330. SINGAPORE PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 331. SINGAPORE PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 332. SINGAPORE PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 333. SINGAPORE PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 334. SINGAPORE PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
• TABLE 335. SINGAPORE PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 336. SINGAPORE PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 337. SINGAPORE PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 338. SINGAPORE PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 339. SINGAPORE PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 340. SINGAPORE PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 341. SINGAPORE PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
• TABLE 342. SINGAPORE PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 343. SINGAPORE PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 344. SINGAPORE PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 345. SINGAPORE PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
• TABLE 346. SINGAPORE PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
• TABLE 347. SINGAPORE PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
• TABLE 348. SOUTH KOREA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 349. SOUTH KOREA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 350. SOUTH KOREA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 351. SOUTH KOREA PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 352. SOUTH KOREA PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
• TABLE 353. SOUTH KOREA PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 354. SOUTH KOREA PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 355. SOUTH KOREA PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 356. SOUTH KOREA PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 357. SOUTH KOREA PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 358. SOUTH KOREA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 359. SOUTH KOREA PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
• TABLE 360. SOUTH KOREA PROTEOMICS MARKET SIZE, BY CLINIC

The Proteomics Market was valued at USD 31.78 billion in 2023, expected to reach USD 36.05 billion in 2024, and is projected to grow at a CAGR of 14.67%, to USD 82.90 billion by 2030.

Proteomics, an extensive field of study of proteins, their structures, and functions, is crucial in understanding biological processes and mechanisms. At its core, the scope of proteomics extends from identifying proteins to analyzing their interactions, helping drive advances in personalized medicine and drug discovery. The necessity of proteomics lies in its potential to unravel complex cellular functions, offering deeper insights into disease mechanisms and the effectiveness of therapeutic interventions. Its applications span clinical diagnostics, biomarker discovery, and systems biology, with end-use sectors including pharmaceuticals, biotechnology, and academic research. Market insights indicate that key growth factors include advancements in mass spectrometry technology, increasing research activities in drug discovery, and rising demand for personalized medicine. Potential opportunities abound, such as developing next-generation proteomics technologies, expanding into untapped emerging markets, and forging strategic partnerships to enhance R&D capabilities. To seize these opportunities, businesses should focus on developing cost-effective and high-throughput technologies while simultaneously advocating for increased funding and collaboration in the proteomics field. However, the market also faces limitations, such as the high cost of instruments and technical complexity, which pose significant barriers to broader adoption. Fragmentation in standardization, lack of skilled personnel, and data management challenges further complicate growth prospects. Despite these challenges, promising areas for innovation include integrating proteomics with genomics and other omics domains, developing AI-driven data analysis tools, and enhancing method standardization to improve reproducibility. The proteomics market is inherently dynamic and competitive, characterized by rapid technological innovations and constant evolution, making it essential for players to maintain agile strategies to address challenges and meet emerging demands. To remain competitive, companies should commit to continuous investment in R&D, foster interdisciplinary collaborations, and prioritize customer-centric approaches that align with evolving market needs.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Proteomics Market

The Proteomics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing use in cancer treatment and need for personalized medicine
  • Rise in adoption of bioinformatics software & services for proteomics studies
  • Government initiatives for human proteome organization and proteomics standards
• Market Restraints
  • High cost associated with proteomics data repository management
• Market Opportunities
  • Significant investment in research & developments of proteomics technique
  • Emerging investments in proteomics biomarker discovery
• Market Challenges
  • Peptide identification limitations in proteomics

Porter's Five Forces: A Strategic Tool for Navigating the Proteomics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Proteomics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Proteomics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Proteomics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Proteomics Market

A detailed market share analysis in the Proteomics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Proteomics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Proteomics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Proteomics Market

A strategic analysis of the Proteomics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Proteomics Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Applied Biomics, Inc., Bio-Rad Laboratories, Inc., Biognosys AG, Bruker Corporation, Cellenion SASU by Bico Group AB, Charles River Laboratories, Inc., Creative Biolabs, Inc., Creative Proteomics, Danaher Corporation, GE Healthcare, Illumina, Inc., IsoPlexis Corporation, Luminex Corporation, Merck KGaA, MRM Proteomics, Inc., Nautilus Biotechnology Inc., NEO Proteomics, Inc., Olink Holding AB, Perkinelmer, Inc., Poochon Scientific, LLC, Precision Proteomics Inc., Promega Corporation, PROMISE Proteomics, Proteome Sciences PLC, Proteomics International, Shantani Proteome Analytics Pvt. Ltd., Thermo Fisher Scientific, Inc., VProteomics, and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Proteomics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Chromatography, Edman Sequencing, Electrophoresis, Mass Spectrometry, Protein Fractionation, Protein Microarrays, Surface Plasmon Resonance, and X Ray Crystallography. The Chromatography is further studied across Affinity Chromatography, Gas Chromatography, Ion Chromatography, Liquid Chromatography, and Superficial Chromatography. The Electrophoresis is further studied across Capillary Electrophoresis and Gel Electrophoresis. The Mass Spectrometry is further studied across Fourier Transform Mass Spectrometry and Tandem Mass Spectrometry. The Protein Microarrays is further studied across Biochip and Functional Protein Microarray.
• Based on Instrument Type, market is studied across Analytical Instruments, Reagents & Consumables, and Software. The Analytical Instruments is further studied across Chromatography Instruments and Spectrometers. The Reagents & Consumables is further studied across Buffers and Stains & Dyes. The Software is further studied across Bioinformatics Databases, Bioinformatics Tools, Data Acquisition Software, and Data Analysis Software.
• Based on Services, market is studied across Bioinformatics Services and Core Proteomics Services.
• Based on Application, market is studied across Biomarker Identification, Clinical Diagnostics, and Drug Discovery. The Biomarker Identification is further studied across Cancer Biomarkers and Cardiovascular Biomarkers. The Clinical Diagnostics is further studied across Disease Diagnosis and Therapeutic Drug Monitoring. The Drug Discovery is further studied across Lead Compound Identification and Target Identification.
• Based on End User, market is studied across Academic & Research Institutes, Hospital & Diagnostic Centers, and Pharmaceutical Companies. The Academic & Research Institutes is further studied across Core Research Facilities and University Labs. The Hospital & Diagnostic Centers is further studied across Clinical Testing Departments and Pathology Labs. The Pharmaceutical Companies is further studied across Drug Manufacturing Unit and R&D Laboratories.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing use in cancer treatment and need for personalized medicine
    • 5.1.1.2. Rise in adoption of bioinformatics software & services for proteomics studies
    • 5.1.1.3. Government initiatives for human proteome organization and proteomics standards
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with proteomics data repository management
  • 5.1.3. Opportunities
    • 5.1.3.1. Significant investment in research & developments of proteomics technique
    • 5.1.3.2. Emerging investments in proteomics biomarker discovery
  • 5.1.4. Challenges
    • 5.1.4.1. Peptide identification limitations in proteomics
• 5.2. Market Segmentation Analysis
  • 5.2.1. Technology: Rising demand for chromatography due to the precision and reliability
  • 5.2.2. Application: Utilization of proteomics in clinical diagnostics for early disease detection, prognosis, and personalized treatment strategies
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Proteomics Market, by Technology

• 6.1. Introduction
• 6.2. Chromatography
  • 6.2.1. Affinity Chromatography
  • 6.2.2. Gas Chromatography
  • 6.2.3. Ion Chromatography
  • 6.2.4. Liquid Chromatography
  • 6.2.5. Superficial Chromatography
• 6.3. Edman Sequencing
• 6.4. Electrophoresis
  • 6.4.1. Capillary Electrophoresis
  • 6.4.2. Gel Electrophoresis
• 6.5. Mass Spectrometry
  • 6.5.1. Fourier Transform Mass Spectrometry
  • 6.5.2. Tandem Mass Spectrometry
• 6.6. Protein Fractionation
• 6.7. Protein Microarrays
  • 6.7.1. Biochip
  • 6.7.2. Functional Protein Microarray
• 6.8. Surface Plasmon Resonance
• 6.9. X Ray Crystallography

7. Proteomics Market, by Instrument Type

• 7.1. Introduction
• 7.2. Analytical Instruments
  • 7.2.1. Chromatography Instruments
  • 7.2.2. Spectrometers
• 7.3. Reagents & Consumables
  • 7.3.1. Buffers
  • 7.3.2. Stains & Dyes
• 7.4. Software
  • 7.4.1. Bioinformatics Databases
  • 7.4.2. Bioinformatics Tools
  • 7.4.3. Data Acquisition Software
  • 7.4.4. Data Analysis Software

8. Proteomics Market, by Services

• 8.1. Introduction
• 8.2. Bioinformatics Services
• 8.3. Core Proteomics Services

9. Proteomics Market, by Application

• 9.1. Introduction
• 9.2. Biomarker Identification
  • 9.2.1. Cancer Biomarkers
  • 9.2.2. Cardiovascular Biomarkers
• 9.3. Clinical Diagnostics
  • 9.3.1. Disease Diagnosis
  • 9.3.2. Therapeutic Drug Monitoring
• 9.4. Drug Discovery
  • 9.4.1. Lead Compound Identification
  • 9.4.2. Target Identification

10. Proteomics Market, by End User

• 10.1. Introduction
• 10.2. Academic & Research Institutes
  • 10.2.1. Core Research Facilities
  • 10.2.2. University Labs
• 10.3. Hospital & Diagnostic Centers
  • 10.3.1. Clinical Testing Departments
  • 10.3.2. Pathology Labs
• 10.4. Pharmaceutical Companies
  • 10.4.1. Drug Manufacturing Unit
  • 10.4.2. R&D Laboratories

11. Americas Proteomics Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Proteomics Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Proteomics Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. SPOC Proteomics launched customizable SPOC biosensors for beta testing, announcing breakthrough SPR technology set to transform proteomics
  • 14.3.2. Bruker launched timsTOF Ultra 2, a state-of-the-art mass spectrometry device enhancing single-cell proteomics with advanced software integration
  • 14.3.3. Biognosys and Alamar Biosciences partner to integrate NULISA assays and enhance DIA-MS platform for advanced proteomics research
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. Applied Biomics, Inc.
• 3. Bio-Rad Laboratories, Inc.
• 4. Biognosys AG
• 5. Bruker Corporation
• 6. Cellenion SASU by Bico Group AB
• 7. Charles River Laboratories, Inc.
• 8. Creative Biolabs, Inc.
• 9. Creative Proteomics
• 10. Danaher Corporation
• 11. GE Healthcare
• 12. Illumina, Inc.
• 13. IsoPlexis Corporation
• 14. Luminex Corporation
• 15. Merck KGaA
• 16. MRM Proteomics, Inc.
• 17. Nautilus Biotechnology Inc.
• 18. NEO Proteomics, Inc.
• 19. Olink Holding AB
• 20. Perkinelmer, Inc.
• 21. Poochon Scientific, LLC
• 22. Precision Proteomics Inc.
• 23. Promega Corporation
• 24. PROMISE Proteomics
• 25. Proteome Sciences PLC
• 26. Proteomics International
• 27. Shantani Proteome Analytics Pvt. Ltd.
• 28. Thermo Fisher Scientific, Inc.
• 29. VProteomics
• 30. Waters Corporation